Drug Profile
Research programme: selective androgen receptor antagonists - Ligand
Alternative Names: AiPC program - LigandLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ligand Pharmaceuticals
- Class
- Mechanism of Action Selective androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acne; Alopecia; Prostate cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Acne in USA
- 16 Jul 2016 No recent reports of development identified for research development in Alopecia in USA
- 16 Jul 2016 No recent reports of development identified for research development in Prostate-cancer in USA